MARINAZZO, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 667
EU - Europa 398
AS - Asia 185
SA - Sud America 3
OC - Oceania 1
Totale 1.254
Nazione #
US - Stati Uniti d'America 658
CN - Cina 117
SE - Svezia 92
IT - Italia 74
IE - Irlanda 57
UA - Ucraina 57
FI - Finlandia 36
KR - Corea 30
DE - Germania 29
FR - Francia 26
SG - Singapore 15
CA - Canada 9
GB - Regno Unito 8
PH - Filippine 7
AT - Austria 6
VN - Vietnam 6
PL - Polonia 5
TH - Thailandia 5
AR - Argentina 3
CH - Svizzera 2
GR - Grecia 2
JP - Giappone 2
RS - Serbia 2
MK - Macedonia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.254
Città #
Chandler 150
Beijing 95
Houston 76
Dearborn 68
Dublin 57
Nyköping 33
Jacksonville 27
Ashburn 23
Fairfield 19
Princeton 18
Torino 18
Wilmington 15
Medford 14
Villeurbanne 13
Ann Arbor 12
San Mateo 11
Woodbridge 10
Singapore 9
Boston 8
New York 8
Seattle 8
Toronto 8
Boardman 6
Cambridge 6
Munich 6
Vienna 6
Kunming 5
Nanjing 5
Redwood City 5
Pisa 4
Turin 4
Dong Ket 3
Milan 3
Belgrade 2
Buenos Aires 2
Changchun 2
Chengdu 2
Demotte 2
Falls Church 2
Fremont 2
Jinan 2
Mountain View 2
Osaka 2
San Diego 2
Verona 2
Warsaw 2
Washington 2
Wettingen 2
Apo 1
Auckland 1
Bitola 1
Bologna 1
Buffalo 1
Burnley 1
Carmagnola 1
Costa Mesa 1
Crema 1
Florence 1
Guangzhou 1
Hefei 1
Helsinki 1
Kharkiv 1
Little Rock 1
Montreal 1
Norwalk 1
Phoenix 1
Quzhou 1
Saint Petersburg 1
Taipei 1
Tappahannock 1
Velletri 1
Venezia 1
Wuhan 1
Totale 808
Nome #
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE 165
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 105
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans 96
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 91
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 79
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 76
METABOLIC AND CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT 76
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 73
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement 68
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 67
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 63
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 61
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS 60
Growth hormone treatment in human ageing: benefits and risks 58
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 57
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 57
LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS 44
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 9
Totale 1.305
Categoria #
all - tutte 4.134
article - articoli 0
book - libri 0
conference - conferenze 1.917
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020239 3 1 4 30 26 95 37 9 5 15 12 2
2020/2021129 24 5 7 3 24 5 8 9 12 12 9 11
2021/2022185 1 1 3 13 12 2 29 14 10 33 32 35
2022/2023325 29 25 8 46 31 88 20 21 30 12 11 4
2023/202496 19 13 10 7 2 17 0 4 1 7 2 14
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.305